Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 28Carcinoma, Non-Small-Cell Lung 15Squamous Cell Carcinoma of Head and Neck 14Neoplasms 8Colonic Neoplasms 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Squamous Cell 4Carcinoma 4Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Thyroid Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Endometrial Neoplasms 2Breast Neoplasms 2Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma 1Recurrence 1Pharyngeal Neoplasms 1Neurofibromatosis 2 1

Interventions

pembrolizumab 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Cetuximab × 30 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡